A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
NCT06586216
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
PF-07817883
Sponsor
Pfizer